Drugs / Ketorolac-Phenylephrine Ophthalmic 0.3%-1% Intraocular Solution
Ketorolac-Phenylephrine Ophthalmic 0.3%-1% Intraocular Solution
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05158699 Comparator | Oct 2021 → Aug 2024 | cataract, cystoid macular edema | Luigi Rondas | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ketorolac-Phenylephrine Ophthalmic 0.3%-1% Intraocular Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05158699 ↗ |
| Route | Other | “intracameral injection of ketorolac tromethamine solution during cataract surgery (Omidria)” NCT05158699 ↗ |